Functional Committees | INVESTORS | beiley biofund

Functional Committees

TW EN

INVESTORS

Functional Committee

Audit Committee

Beiley Biofund has established an Audit Committee under the Board of Directors, which is composed of all independent directors. The primary purpose of the Audit Committee's operation is to oversee the fair presentation of the company's financial statements, the appointment (dismissal), independence, and performance of the certifying certified public accountants (CPAs), the effective implementation of internal controls, compliance with relevant laws and regulations, and the management of existing or potential risks. 
The evaluation results are submitted to the Board of Directors for discussion.
The Audit Committee is convened by Independent Director Li, Chia-Hua and meets at least once per quarter.
 

Major Responsibilities

  1. Fair presentation of the company's financial statements.
  2. Appointment (dismissal), independence, and performance of the certifying CPAs.
  3. Effective implementation of the company's internal controls, and compliance with relevant laws and regulations.
  4. Management of existing or potential risks of the company.

Attendance of the Audit Committee Members (Year 2026)
1st Term

Most Recent Meeting Date: April 28, 2026

Position Name Actual Attendance (B) Delegated Attendance Actual Attendance Rate (%) (B/A) Remarks
Independent director (Convener) Chia-Hwa Li 3 0 100%
Independent director (Member) Jui-Te YU 3 0 100%
Independent director (Member) Hui-E Chen 3 0 100%







 



​​​​​​

The operational status in 2026 is as follows:
Meeting date Session Motion Resolution results of the Audit Committee The Company’s response to the opinions of the Audit Committee members
115/2/6 1st Meeting of the 1st Term Proposal for the election of the Convener and Chairman of the Company’s 1st Audit Committee. Approved as proposed by all attending members None
115/3/26 2nd Meeting of the 1st Term Proposal for the compilation of the Company’s Plan to Improve Self-Preparation Capability of Financial Reports. Approved as proposed by all attending members None
Proposal for applying for the Company's stock listing (over-the-counter). Approved as proposed by all attending members None
Proposal regarding the public underwriting of new shares issued prior to the Company's initial listing (OTC), and proposing that original shareholders waive their pre-emptive rights to subscribe to the cash capital increase conducted prior to listing (OTC). Approved as proposed by all attending members None
Proposal to amend the Information Security Management Measures. Approved as proposed by all attending members None
Proposal to lift non-compete restrictions on directors and their representatives. Approved as proposed by all attending members None
115/4/28 3rd Meeting of the 1st Term Proposal for the 2025 Business Report and Financial Report. Approved as proposed by all attending members None
Proposal for the distribution method and amount of employee compensation and directors/supervisors' remuneration for 2025. Approved as proposed by all attending members None
Proposal for the 2025 earnings distribution. Approved as proposed by all attending members None
Proposal for the 2025 capitalization of earnings and issuance of new shares. Approved as proposed by all attending members None
Proposal for the assessment of independence and suitability of the certifying CPAs. Approved as proposed by all attending members None
Proposal for the appointment and remuneration of the certifying CPAs. Approved as proposed by all attending members None
Proposal to amend the Articles of Incorporation. Approved as proposed by all attending members None
Proposal to amend the Procedures for Acquisition or Disposal of Assets. Approved as proposed by all attending members None
Proposal to authorize senior executives to engage in derivative commodity supervision and management. Approved as proposed by all attending members None
Proposal to amend the Operational Procedures for Endorsements and Guarantees. Approved as proposed by all attending members None
Proposal to amend the Rules of Procedure for Shareholders' Meetings. Approved as proposed by all attending members None
Proposal to amend the Regulations for Election of Directors and Supervisors. Approved as proposed by all attending members None
Proposal to amend the Code of Integrity Management. Approved as proposed by all attending members None
Proposal to amend the Procedures for Integrity Management and Guidelines for Conduct. Approved as proposed by all attending members None
Proposal to amend the Code of Moral Conduct. Approved as proposed by all attending members None
Proposal to amend the Investment Cycle. Approved as proposed by all attending members None
Proposal to amend the Acquisition Cycle of Property, Plant, and Equipment. Approved as proposed by all attending members None
Proposal to amend the Investment Business and Risk Management Measures. Approved as proposed by all attending members None
Proposal to formulate the Conflict of Interest Prevention Management Policy. Approved as proposed by all attending members None

If you have any investor-related inquiries

please feel free to contact us.

Investor Relations Email

ir@beileybiofund.com

Spokesperson

Che Hsu | General Manager

TEL:+886-2-8979-5678

Acting Spokesperson

Penny Wu | Manager

TEL:+886-2-8979-5678

PORTFOLIO CONTACT US

In compliance with EU personal data protection laws, we are committed to protecting and providing you with control over your personal data. By clicking "Accept All", you allow us to place cookies to enhance your experience on this site, help us analyze site performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. By clicking "Agree" you agree to the current settings. For more information, please visit the Privacy Statement.

This website uses cookies

In compliance with EU personal data protection laws, we are committed to protecting your personal data and providing you with control over it. By clicking "Agree", you allow us to place cookies to improve your experience on this site, help us analyze site performance and usage, and allow us to deliver relevant marketing content.

By clicking "Only necessary" you allow us to place only necessary cookies. The website cannot function without these cookies and you cannot switch them off on your system. These cookies are typically set only in response to an action you perform (i.e. a service request), such as setting privacy preferences, logging in, or filling in a form. You can set your browser to block or prompt you for these cookies, but this may prevent some site features from working.

About cookies Google Privacy Policy